Interpretation and Optimization of the Dissolution Specifications for a Modified Release Product with an In Vivo–In Vitro Correlation (IVIVC)
Inconsistencies in Rationale Underlying Official USP Dissolution Rate Specifications for Nitrofurantoin
Dissolution Edge Charts for Immediate Release Products and Their Applications: a Simulation Study to Aid the Setting of Specifications
Establishing Clinically Relevant Specifications for Carbamazepine Tablets Using Physiologically Based Pharmacokinetic Modeling
Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling
